Crawford Lake Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Crawford Lake Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $4.06 Million - $7.68 Million	-358,082 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $1.39 Million - $7.67 Million	358,082 New	358,082 $7.26 Million
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $2.06 Million - $3.23 Million	-455,656 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $2.6 Million - $3.14 Million	455,656	455,656 $2.86 Million

190

56.4M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.04B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.